We are live on
!
Find out more
CCM
Catapult Capital Management Portfolio holdings
AUM
$265M
1-Year Est. Return
21.83%
This Fund
S&P 500
This Quarter
Est. Return
+5.74%
1 Year Est. Return
+21.83%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$696M
AUM Growth
-$122M
(-15%)
Cap. Flow
-$135M
Cap. Flow
% of AUM
-19.45%
Top 10 Holdings %
Top 10 Hldgs %
23.76%
Holding
329
New
119
Increased
34
Reduced
64
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$23.2M |
| 2 |
PepsiCo
PEP
|
+$13.1M |
| 3 |
AbbVie
ABBV
|
+$10.1M |
| 4 |
Elevance Health
ELV
|
+$9.59M |
| 5 |
Abbott
ABT
|
+$8.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$22.4M |
| 2 |
Pfizer
PFE
|
+$18M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$13.1M |
| 4 |
Pediatrix Medical
MD
|
+$11.2M |
| 5 |
Danaher
DHR
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 42.68% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Industrials | 7.26% |
| 4 | Consumer Staples | 5.08% |
| 5 | Communication Services | 3.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HBI
26
DELISTED
Hanesbrands
HBI
| $5.61M | 0.81% |
168,455
-5,285
| -3% | -$173K |
|
27
PUT
Boeing
BA
$175B
| $5.55M | 0.8% |
+40,000
| New | +$5.83M |
|
28
Conagra Brands
CAG
$7.19B
| $5.39M | 0.77% |
+158,506
| New | +$4.76M |
|
|
THOR
29
DELISTED
THORATEC CORPORATION
THOR
| $5.37M | 0.77% |
120,533
-79,467
| -40% | -$3.48M |
|
|
TWX
30
DELISTED
Time Warner Inc
TWX
| $5.29M | 0.76% |
60,540
-5,657
| -9% | -$483K |
|
31
Molson Coors Class B
TAP
$7.79B
| $5.26M | 0.76% |
75,284
+4,636
| +7% | +$345K |
|
|
AMAG
32
DELISTED
AMAG Pharmaceuticals
AMAG
| $5.18M | 0.74% |
75,000
+30,000
| +67% | +$1.89M |
|
33
AtriCure
ATRC
$2.04B
| $5.17M | 0.74% |
210,000
-15,000
| -7% | -$335K |
|
|
HOT
34
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $5.14M | 0.74% |
63,353
+34,921
| +123% | +$2.92M |
|
35
Align Technology
ALGN
$12.4B
| $5.02M | 0.72% |
+80,000
| New | +$4.73M |
|
36
UnitedHealth
UNH
$383B
| $4.88M | 0.7% |
+40,000
| New | +$4.73M |
|
37
Idexx Laboratories
IDXX
$44.1B
| $4.81M | 0.69% |
+75,000
| New | +$5.19M |
|
38
Walt Disney
DIS
$167B
| $4.77M | 0.69% |
+41,824
| New | +$4.59M |
|
39
CALL
The Mosaic Company
MOS
$7.24B
| $4.68M | 0.67% |
+100,000
| New | +$4.54M |
|
|
40
CALL
PepsiCo
PEP
$191B
| $4.67M | 0.67% |
+50,000
| New | +$4.78M |
|
41
Jack in the Box
JACK
$312M
| $4.66M | 0.67% |
52,892
+4,664
| +10% | +$419K |
|
|
MIC
42
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $4.59M | 0.66% |
55,555
-77,045
| -58% | -$6.51M |
|
43
PPG Industries
PPG
$25B
| $4.57M | 0.66% |
39,839
+7,477
| +23% | +$854K |
|
44
PUT
Macy's
M
$6.56B
| $4.55M | 0.65% |
+67,500
| New | +$4.56M |
|
45
Mohawk Industries
MHK
$7.29B
| $4.52M | 0.65% |
23,678
-5,799
| -20% | -$1.07M |
|
|
SUNE
46
DELISTED
SUNEDISON, INC COM
SUNE
| $4.29M | 0.62% |
143,252
+31,119
| +28% | +$886K |
|
|
WCG
47
DELISTED
Wellcare Health Plans, Inc.
WCG
| $4.24M | 0.61% |
50,000
-20,000
| -29% | -$1.69M |
|
48
Biogen
BIIB
$30.7B
| $4.04M | 0.58% |
+10,000
| New | +$4.01M |
|
49
CALL
United States Oil Fund
USO
$2.12B
| $3.98M | 0.57% |
25,000
-37,500
| -60% | -$5.95M |
|
|
TYC
50
CALL
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $3.85M | 0.55% |
+95,500
| New | +$4.07M |
|
Similar funds
LOCB
AF
TCOTO
DCM
SCA
LPVHS
ATC
TFF
Catapult Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Catapult Capital Management held 329 positions worth $696M, down 15% from $818M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Catapult Capital Management withdrew a net $135M in Q2 2015, closing 111 positions and reducing 64 holdings. Its most notable exit was Pfizer, an estimated $18M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Catapult Capital Management opened a new position in Zoetis worth $23.5M.
- Catapult Capital Management's largest Q2 2015 buy was Zoetis: 486,665 shares worth $23.5M.
- Catapult Capital Management added most to AbbVie in Q2 2015, an estimated $10.1M increase.
- Catapult Capital Management's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $22.4M.
- Catapult Capital Management fully exited Pfizer in Q2 2015, selling an estimated $18M.
- Catapult Capital Management's ten largest holdings make up 24% of its $696M portfolio in Q2 2015.
- Catapult Capital Management opened 119 new positions and closed 111 in Q2 2015.
- Catapult Capital Management's portfolio value fell 15% quarter-over-quarter to $696M.
Based on Catapult Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.